Skip to main content
TipRanks
Go Ultimate75% OFF

Bayer (0P6S) Share Price & Analysis

38 Followers

0P6S Stock Chart & Stats

€57.00€0.48(0.85%)
At close: 4:30 PM GMT
€45€50€55Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
EUR 56.74 - EUR 57.36
52-Week Range
EUR 26.67 - EUR 57.84
Previous Close
EUR 56.52
Volume
N/A
Average Volume (3M)
622.69K
Market Cap
EUR 55.53B
Enterprise Value
EUR 84.40B
Total Cash (Recent Filing)
EUR 12.60B
Total Debt (Recent Filing)
EUR 43.42B
Price to Earnings (P/E)
―
Beta
1.41
Next Earnings
Feb 24, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
0.19%

Bulls Say, Bears Say

Bulls Say

Pharmaceutical Pipeline Momentum

The China approval gives Bayer a meaningful pipeline asset and expands its pharmaceutical growth options beyond existing products. Asundexian’s first-in-class status may support further regulatory filings, future commercialization, and a broader platform for rebuilding durable Pharma growth.

Positive Operating Cash Generation

Consistently positive operating cash flow shows that Bayer’s established Pharmaceuticals and Crop Science businesses continue to generate liquidity from operations. This provides an internal funding base for research, debt reduction, and investment, even though recent free-cash-flow performance has weakened.

Improving Operating Outlook

The upgraded guidance indicates improving execution and gives greater support to Bayer’s near-term operating trajectory. Higher expected EBITDA and better cash guidance could strengthen financial flexibility, while management’s focus on productivity and balance-sheet improvement supports longer-term recovery.

Bears Say

Recurring Net Losses

Repeated net losses indicate that Bayer’s substantial revenue base is not consistently converting into shareholder earnings. Persistent bottom-line weakness can constrain reinvestment, reduce financial flexibility, and make future performance more dependent on successful cost, portfolio, and pipeline execution.

Sharp Free-cash-flow Deterioration

The steep decline in free cash flow signals weaker cash conversion or materially higher cash outflows, reducing confidence in the durability of internally generated funds. This can limit debt reduction and investment capacity while increasing pressure on management to restore cash generation.

High Financial Leverage

Bayer’s historically elevated leverage reduces resilience while earnings remain weak and cash flow is volatile. A large debt burden can absorb operating cash through financing obligations, constrain capital allocation, and leave less flexibility to fund pipeline development or withstand business pressure.

Bayer News

0P6S FAQ

What was Bayer’s price range in the past 12 months?
Bayer lowest share price was €26.67 and its highest was €57.84 in the past 12 months.
What is Bayer’s market cap?
Bayer’s market cap is €55.53B.
When is Bayer’s upcoming earnings report date?
Bayer’s next earnings report is estimated for Feb 24, 2027 (not yet confirmed), which is in 99 days.
How were Bayer’s earnings last quarter?
Bayer released its earnings results on Nov 03, 2026. The company reported €0.31 earnings per share for the quarter, missing the consensus estimate of €0.387 by -€0.077.
Is Bayer overvalued?
According to Wall Street analysts Bayer’s price is currently Undervalued.
Does Bayer pay dividends?
Bayer does not currently pay dividends.
What is Bayer’s EPS estimate?
Bayer’s EPS estimate is 0.60.
How many shares outstanding does Bayer have?
Bayer has 982,424,100 shares outstanding.
What happened to Bayer’s price movement after its last earnings report?
Bayer reported an EPS of €0.31 in its last earnings report, missing expectations of €0.387. Following the earnings report the stock price went up 5.758%.
Which hedge fund is a major shareholder of Bayer?
Currently, no hedge funds are holding shares in GB:0P6S
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology